Can anti-cancer drugs be used as an effective therapy for the treatment of Alzheimer’s disease?

Background Worldwide, around 50 million people have dementia. According to the World Health Organization reports, this number is expected to increase threefold by 2050. Alzheimer’s disease (AD) is the most common type of dementia, which is characterised by deterioration in cognition and behaviour. The underlying aetiopathogenesis of AD is still little understood. The amyloid plaques theory and tau hyperphosphorylation are […]

Read More…

The role of extra chromosomal circular DNA in rapid adaption to glyphosate resistance in pigweed

eccDNAs could constitute the targets of the next generation of herbicides and anti-cancer drugs.

Plants, like other living organisms, have genetic stress-avoidance mechanisms that allow them to become resistant to specific chemicals when continuously exposed to them. Dr Christopher Saski from Clemson University and Dr William Molin from the U.S. Department of Agriculture are researching the extrachromosomal circular DNA (eccDNA) structure known as the replicon of pigweed, which contains the EPSPS gene, the gene […]

Read More…

Targeting melanoma cells with a drug-infused graphene matrix

The researchers are developing testing platforms for novel therapeutic drug combinations for patients with metastatic melanoma.

Dr Livia Sima of the Institute of Biochemistry of the Romanian Academy and Dr Emanuel Axente of the National Institute for Laser, Plasma, and Radiation Physics in Romania are developing novel platforms for screening of therapeutic drug combinations for patients with metastatic melanoma. Their most recent work involves investigating a method which can be used to screen potential drug candidates. […]

Read More…

Thank you for expressing interest in joining our mailing list and community. Below you can select how you’d like us to interact with you and we’ll keep you updated with our latest content.

You can change your preferences or unsubscribe by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at at any time and if you have any questions about how we handle your data, please review our privacy agreement.

Would you like to learn more about our services?

We use MailChimp as our marketing automation platform. By clicking below to submit this form, you acknowledge that the information you provide will be transferred to MailChimp for processing in accordance with their Privacy Policy and Terms.

Subscribe to our FREE PUBLICATION